(2S,5S,8S,11S,14S,17S,20S)-2-(4-aminobutyl)-5,8,11,14,17-pentakis(carboxymethyl)-4,7,10,13,16,19-hexaoxo-20-(8-(4,5,6,7-tetrabromo-1H-benzo[d]imidazol-1-yl)octanamido)-3,6,9,12,15,18-hexaazadocosane-1,22-dioic acid (Compound)
Description: A compound in the knowledge graph
Analyze
CFDE DD-Knowledge Graph
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (2S,5S,8S,11S,14S,17S,20S)-2-(4-aminobutyl)-5,8,11,14,17-pentakis(carboxymethyl)-4,7,10,13,16,19-hexaoxo-20-(8-(4,5,6,7-tetrabromo-1H-benzo[d]imidazol-1-yl)octanamido)-3,6,9,12,15,18-hexaazadocosane-1,22-dioic acid's neighborhood in the knowledge graph.
Knowledge Graph Assertions
Source | Relation | Target | Evidence | |
|---|---|---|---|---|
| Loading results... | ||||
DISPLAY PER PAGE
10
@CFDE Workbench 2024
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2024